# Yaya Capital

> Yaya Capital is a VC fund backing Health Care, Artificial Intelligence and Machine Learning. See 8 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 8
- Last investment: Oct 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/yaya-capital/
- Website: https://www.yaya.capital/

Yaya Capital is a Venture capital and Private equity firm.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $8.8M–$52M |
| Series B | $30M–$175M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 5 | 63% |
| Artificial Intelligence | 3 | 38% |
| Machine Learning | 2 | 25% |
| Fitness | 1 | 13% |
| Medical | 1 | 13% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 4 | 50% |
| Series B | 2 | 25% |
| Venture - Series Unknown | 1 | 13% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Brazil | 3 | 38% |
| United States | 3 | 38% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ISA Saúde | ISA lab is to deliver the best solution for health and offers a humanized service. ISA is an online platform where one can select the process like examination, test, or vaccine. Then schedule and make payment online, receive ISA wherever one wants. Finally, they offer a facility to check the result online and rate their service. | $30M | Series B | Oct 28, 2025 |  |
| NeuralMed | NeuralMed is a native healthcare startup that analyzes all types of unstructured data from various sources to create a single safe and reliable data matrix. It develops solutions based on proprietary algorithms that maximize the full potential of real-time medical data. Its algorithms can organize patient flow by criticality and assist doctors inidentifying pathologies and structuring reports based on the analysis of free texts and images. Its solutions are dependable and easily integrated into any system, resulting in higher user adherence. |  | Venture - Series Unknown | Nov 16, 2022 |  |
| XP Health | XP Health is a health tech startup introducing a new kind of vision benefit for employees leveraging machine learning.Founded in 2019 by Antonio Moraes and James Wong, XP Health is an AI-powered vision benefits platform for employees and their families to get frames from the world’s leading designers like Tom Ford, Ray-Ban, Armani, Gucci, Coach.Its proprietary deep learning model uses facial recognition technology that recommends the best frames based on facial dimensions with 98% accuracy. The company is working with companies like Chegg, Zenefits, and Sequoia Consulting Group. | $17.1M | Series A | Sep 28, 2022 |  |
| ISA Saúde | ISA lab is to deliver the best solution for health and offers a humanized service. ISA is an online platform where one can select the process like examination, test, or vaccine. Then schedule and make payment online, receive ISA wherever one wants. Finally, they offer a facility to check the result online and rate their service. | $17M | Series A | Aug 09, 2022 |  |
| Endpoint Health | Endpoint Health is a precision immunology company that is breaking the efficacy barrier of traditional pharma's “one-size-fits-all” drug development strategy by developing precision therapies with outsized efficacy potential in autoimmune and inflammatory conditions. They’re accomplishing this by leveraging OMNAI, their proprietary AI-poweredpatient discovery platform, to identify and match high-potential therapies to the patients most likely to respond. | $52M | Series A | Jun 02, 2022 |  |
| Klivo | Klivo is a platform that connects multidisciplinary healthcare with the help of an application. | $8.8M | Series A | Mar 07, 2022 |  |
| Endpoint Health | Endpoint Health is a precision immunology company that is breaking the efficacy barrier of traditional pharma's “one-size-fits-all” drug development strategy by developing precision therapies with outsized efficacy potential in autoimmune and inflammatory conditions. They’re accomplishing this by leveraging OMNAI, their proprietary AI-poweredpatient discovery platform, to identify and match high-potential therapies to the patients most likely to respond. |  | Series A | Feb 09, 2022 |  |
| Metagenomi | Metagenomi is using the power of metagenomics and machine learning to discover novel genome editing systems. | $175M | Series B | Jan 25, 2022 |  |

8 of 8 investments shown.

## Co-investors
- [Kortex Ventures](https://shizune.co/investors/profile/kortex-ventures) — VC Fund, 3 deals together
- [GRIDS Capital](https://shizune.co/investors/profile/grids-capital) — VC Fund, 2 deals together
- [Humboldt Fund](https://shizune.co/investors/profile/humboldt-fund) — VC Fund, 2 deals together
- [Lupa Capital](https://shizune.co/investors/profile/lupa-capital) — VC Fund, 2 deals together
- [Mayfield Fund](https://shizune.co/investors/profile/mayfield-fund) — VC Fund, 2 deals together
- [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [DOMO.VC](https://shizune.co/investors/profile/domo-invest) — VC Fund
- [Canary](https://shizune.co/investors/profile/canary-5) — VC Fund

## Featured in investor lists
- [Fitness Investors in Brazil](https://shizune.co/investors/fitness-investors-brazil)
- [Fitness VC Funds in Brazil](https://shizune.co/investors/fitness-vc-funds-brazil)

## FAQ

### What does Yaya Capital invest in?

Yaya Capital invests primarily in Health Care, Artificial Intelligence and Machine Learning startups, most often at Series A and Series B stage. Most of the 8 investments tracked by Shizune back companies in Brazil. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Yaya Capital's check size?

Yaya Capital typically joins rounds of $8.8M–$52M at Series A and $30M–$175M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Yaya Capital participates in.

### When did Yaya Capital last invest?

The most recent investment recorded for Yaya Capital closed in Oct 2025. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co